;and salts, solvates, pharmaceutical compositions, and dosage forms thereof, for use in methods of treating negative symptoms and disorders (e.g., autism disorders, amblyopia, personality disorders, traumatic brain injury), as well as increasing neuroplasticity and promoting neuroprotection in subjects in need thereof."/>
公开/公告号US2020061046A1
专利类型
公开/公告日2020-02-27
原文格式PDF
申请/专利权人 MINERVA NEUROSCIENCES INC.;
申请/专利号US201916547164
发明设计人 REMY HENRI LUTHRINGER;
申请日2019-08-21
分类号A61K31/454;A61P25/28;
国家 US
入库时间 2022-08-21 11:21:47